Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
12 December, 2018 15:21 IST
DB Corp quarterly profit drops 11%
Source: IRIS | 16 May, 2018, 12.31PM
Comments  |  Post Comment

Sudhir Agarwal, Managing Director, D. B. Corp said, "Our performance in the fourth quarter has reflected a culmination of al/ efforts, we have been under taking over the last one year, in implementing editorial and circulation expansion strategies. As evident, both have played out their complimentary roles and we have reported significant circulation-led growth. Our focus markets remains the same in Gujarat, Bihar, and Rajasthan and we are working hard to further increase our circulation nos. in markets, we already enjoy a strong dominance, including MP , CG,
Haryana and Chandigarh.A key aspect of our circulation strategies have been the strong reader engagement initiatives that helped in expandin ur markets and attracting new readers.



D B Corp Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Ashok Leyland signs defence agreement with ELBIT Systems - 12-Dec-2018 09:41
Wipro launches automotive innovation center in Michigan - 12-Dec-2018 09:37
Liva Pharmaceuticals gets USFDA approval for its sANDA - Ranitidine Injection - 12-Dec-2018 09:35
Dr Reddy's Labs launches Omeprazole tablets in US market - 12-Dec-2018 09:31
Strides Vivimed JV receives consent for Albendazole tablets - 12-Dec-2018 09:27
Unichem Lab gets tentative nod for Tadalafil tablets - 12-Dec-2018 09:25
Zydus Wellness gets CCI approval for acquisition of Heinz India - 12-Dec-2018 09:20
Wipro Digital to expand Asia Pacific design capabilities in Australia - 11-Dec-2018 09:26
Wipro Digital to expand Asia Pacific design capabilities in Australia - 11-Dec-2018 09:24
Lupin receives tentative USFDA approval for Apixaban tablets - 11-Dec-2018 09:20
Lupin receives EIR from USFDA for Indore facility - 10-Dec-2018 16:10
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer